December 22, 2025
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreMarch 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreNovember 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreNovember 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreOctober 28, 2025
The advanced liver cancer treatment drugs market is expanding due to increased adoption of systemic therapies over traditional chemotherapy and growing approvals of immuno-oncology agents. North America led the market due to the presence of a well-developed oncology infrastructure....
October 28, 2025
Based on market forecasts, the U.S. oncology sector will expand from USD 72.79 billion in 2024 to USD 211.78 billion by 2034, experiencing a CAGR of 11.75%. The West region led the market due to the vital contribution of California in the oncology studies....
October 27, 2025
Market insights predict, the liquid health supplements industry is expected to grow from USD 24.12 billion in 2024 to USD 73.42 billion by 2034, driven by a CAGR of 11.65%. The liquid health supplements market is on the rise due to rising awareness about health supplements among consumers in fitness communities. North America dominates the market d...
October 24, 2025
Based on market forecasts, the biosynthesis peptide drugs sector will expand from USD 18.31 billion in 2024 to USD 32.88 billion by 2034, experiencing a CAGR of 6.26%. The biosynthesis peptide drugs market is growing, as these drugs offer many advantages, such as low manufacturing cost, reduced contamination, and a simpler manufacturing process tha...
October 24, 2025
The globe is emphasizing the reduction of hypoglycemia risk is fueling the global demand. North America’s growing type 2 DM instances fueled its dominance....
October 17, 2025
According to market projections, the global generic drug CRO market, valued at USD 8.45 billion in 2024, is anticipated to reach USD 11.73 billion by 2034, growing at a CAGR of 3.36% over the next decade. The generic drug CRO market is growing due to increasing demand for affordable healthcare services and the expiration of patents on major medicin...
October 15, 2025
According to market projections, the global anticancer drugs market, valued at USD 167.09 billion in 2024, is anticipated to reach USD 401.32 billion by 2034, growing at a CAGR of 9.14% over the next decade. The growing aging population is more susceptible to cancer, increasing the patient pool for anti-cancer drugs. North America led the global ma...
October 14, 2025
The global over-the-counter (OTC) analgesic market, valued at USD 30.61 billion in 2024, is anticipated to reach USD 44.02 billion by 2034, growing at a CAGR of 3.7% over the next decade. An over-the-counter (OTC) analgesic is a pain-relieving medicine you can buy without a prescription. It helps reduce pain, fever, or inflammation and includes com...
October 14, 2025
The inhaled therapy in respiratory disease market is valued at USD 11.98 billion in 2025 and expected to reach USD 16.22 billion by 2034 at 3.44% CAGR. Dominant segments include bronchodilators (28%), MDIs (35%), COPD (38%), retail pharmacies (60%), and inhaled biologics growing fastest. North America holds 42% share, Asia Pacific fastest-growing. ...
October 14, 2025
According to market projections, the gene therapies for cancer treatment sector is expected to grow from USD 8.28 billion in 2024 to USD 238.77 billion by 2034, reflecting a CAGR of 39.94%. The rising prevalence of cancer and the growing demand for personalized medicines drive the global market. North America dominated due to the availability of st...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com